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and Laércio Joel Franco2
Abstract 
Background: The raising prevalence of weight excess and of non‑communicable diseases in indigenous popula‑
tions, as well as changes in food consumption and reduction in the frequency and intensity of physical activity, sug‑
gest that the prevalence of metabolic syndrome (MS) is also elevated. The objective of this study was to evaluate the 
prevalence of MS and the frequency of its components in the Xavante adult population living in the Indian reserva‑
tions of São Marcos and Sangradouro/Volta Grande, in the state of Mato Grosso, Brazil. A cross‑sectional study was 
carried out among 932 Xavante Indians aged 20 years or more, in the 2008–2012 period. The variables analysed were 
gender, age, weight, height, waist circumference, blood pressure, initial and 2‑h capillary glycemia in a 75 g OGTT, lev‑
els of triglycerides and HDL‑cholesterol. The diagnostic criteria for MS proposed by the IDF and AHA/NHLBI were used.
Results: The prevalence of MS was 66.1 % (95 % CI 63.0–69.2), being 76.2 % (95 % CI 72.4–80.0) in women and 55.6 % 
(95 % CI 51.0–60.2) in men. Women had higher prevalence of MS in all age groups. Elevated waist circumference and 
lower levels of HDL‑cholesterol were the more frequent components in those with MS, and elevated blood pressure 
was the less frequent.
Conclusions: The high prevalence of MS in the Xavante Indians is mainly due to the increased prevalence of weight 
excess that resulted from an intense change in their life‑style, in a short period of time in a population with a genetic 
predisposition. These findings highlight the magnitude of this health problem and make an alert about the necessity 
to implement specific preventive interventions.
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Background
The metabolic syndrome (MS) is defined as a condition 
where risk factors for cardiovascular diseases and diabe-
tes mellitus (DM) occurs in the same individual. Its main 
components are central obesity, hypertension, dyslipi-
demia and abnormalities in the glucose homeostasis [1, 
2].
There are few data about the prevalence of MS in the 
Brazilian Indigenous population. Some reports high-
lighted the alarming increase of weight excess and of 
non-communicable diseases in this population, as well 
changes in their food consumption and reduction in the 
frequency and intensity of physical activity [3–16]. All 
these findings suggest that the prevalence of MS could be 
elevated among Brazilian Indians.
Some studies in specific Brazilian Indigenous commu-
nities already produce concerns about the elevated prev-
alence of MS, that range from 15.5 to 65.3 % [9, 17–20].
The Xavante Indians belong to the Macro-Jê linguis-
tic group and live in a broad region of the Brazilian cen-
tral plateau, known as “cerrado”, and have a low degree 
of admixture confirmed by genome-wide analysis [21]. 
Traditionally hunter-gatherers, and due to conflicts with 
newcomer farmers, they started to be settled in delimi-
tated areas in a process that started in 1957. This new 
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condition produced important changes in their lifestyle, 
became more sedentary and modified their traditional 
diet by incorporating new foods obtained in nearby cit-
ies or through food baskets donated by governmental 
agencies. Thus, important changes have been observed 
in the nutritional and health profile of this population, 
including diseases, such as diabetes, that were previously 
unknown to them [4, 10, 16].
Until now, there was not any information about the fre-
quency of MS in the Xavante population, an Indian group 
with high prevalence of diabetes and weight excess, two 
basic conditions in the genesis of this syndrome [22].
Considering that MS has great clinical relevance, and 
is associated with a higher risk to develop cardiovascular 
diseases and diabetes [1, 2], it is important to know its 
prevalence and so its magnitude to plan and to develop 
specific intervention programs on modifiable risk fac-
tors, particularly in the diet and physical activity. The 
objective of this study was to evaluate the prevalence 
of MS and the frequency of its components in the adult 
Xavante population, from the Indian reservations of São 
Marcos and Sangradouro/Volta Grande, in the state of 
Mato Grosso.
Methods and procedures
Study population
The Xavante Indians are estimated to have 20,000 indi-
viduals and belong to the Macro-Jê linguistic group, 
and live in eight Indian reservations in the state of Mato 
Grosso, Brazil [23–25].
During the field work, the São Marcos and Sangra-
douro Reservations were visited ten times from October 
2010 to January 2012. The total population from these 
two reservations are estimated in 4065 individuals, being 
1582 aged 20 years or more [24, 25].
Local indigenous leaders were previously contacted and 
provided a written consent for the study, and this was used 
to get approval from regulatory agencies to carry out the 
study and to get financial support. Before starting the field 
work, the local leaders were contacted again, and all the 
procedures to be performed were explained. All participants 
agreed to participate and signed an informed consent. For 
the ones who were illiterate (14 %), fingerprints were used to 
document their approval, with the aid of a local leader or a 
Xavante health worker. All examinations and blood sample 
collections were made in the Indian villages.
All individuals aged 20  years or more were invited to 
participate in the study. The acceptance of this survey was 
very high among them, and the non-participants were 
those absent in the village at the time of the survey. Data 
were obtained from 932 Xavante Indians from both sexes.
This survey was approved by the Research Ethics Com-
mittee (CEP) of the Ribeirão Preto Medical School of the 
University of São Paulo, by the Brazilian National Eth-
ics Committee (CONEP), and by the Brazilian National 
Indian Foundation (FUNAI). All procedures were per-
formed in accordance with the ethical principles of the 
2008 Declaration of Helsinki.
Procedures
The variables of interest were: sex, age, weight, height, 
waist circumference, blood pressure, capillary glyce-
mia (basal and 2-h after 75  g of glucose), serum lev-
els of triglyceride and HDL-cholesterol. Weight was 
measured using a portable digital scale (Plenna®), with 
a capacity of 150  kg and precision of 0.1  kg, with the 
individual wearing light clothes and barefoot. Height 
was measured using a portable stadiometer (AlturEx-
ata®), with precision of 0.1 cm. Body mass index (BMI) 
was calculated as the ratio of weight (kg) to the square 
height (m).
The nutritional status was evaluated according to 
the proposed WHO criteria [26] for adults: under-
weight (BMI <18.5  kg/m2); euthrophic (BMI ≥18.5  kg/
m2 and <25.0 kg/m2); overweight (BMI ≥25.0 kg/m2 and 
<30.0 kg/m2); obesity (BMI ≥30.0 kg/m2). For the elderly 
were considered the following cutoff points: underweight 
(BMI  ≤22.0 kg/m2); eutrophic (BMI >22.0  kg/m2  and 
<27.0 kg/m2); Overweight (BMI ≥27.0  kg/m2) [27]. For 
the analysis, the subjects with overweight and obesity 
were grouped in the category of weight excess.
Waist circumference (WC) was measured at the mid-
point between the lowest rib and the upper border of the 
anterior superior iliac crest, with the individual in the 
standing position.
Blood pressure was measured in the left arm from 
seated subjects, after 5  min of rest, using the OMRON 
HEM-742INTC® equipment. Blood pressure was meas-
ured three times and the average of the last two readings 
was taken as final.
Basal capillary glycemia and the sample taken 2 h after 
75 g of anhydrous glucose (Glutol®) were measured by a 
portable glucometer (HemoCue® Glucose 201+).
Blood samples were collected from individuals fast-
ing from 8 to 10 h through vein puncture in the forearm 
using vacuum, sterile, and disposable collectors (Vacu-
otainer®). Blood samples were processed, separated into 
aliquots, and stored at −20  °C before transportation to 
the city of São Paulo for laboratory analysis. Serum levels 
of HDL-cholesterol and triglycerides were measured by 
enzymatic methods.
The diagnosis of MS was made when the individual 
have three or more of the following components [2]:
  • Basal glycemia  >  200  mg/dL or 2-h glyce-
mia > 140 mg/dL or using antidiabetic medication;
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  • HDL-cholesterol <40 mg/dL for men and <50 mg/dL 
for women or drug treatment for low HDL;
  • Triglycerides ≥150 mg/dL or drug treatment for ele-
vated triglycerides;
  • WC ≥94 cm for men and ≥80 cm for women;
  • blood pressure >130/85 mmHg or drug treatment for 
hypertension;
According to the diagnostic criteria for MS, one of the 
components is diabetes or fasting glycemia ≥100  mg/
dL (impaired fasting glucose—IFG). This condition was 
not considered due to difficulties in assuring the fast-
ing condition. The Xavante Indians do not have a regu-
lar schedule for meals and there are cultural barriers to 
understand the need to fast for the purposes of blood 
testing. Due to these difficulties, we decided to consider 
as a proxis of IFG the impaired glucose tolerance—IGT, 
that is 2-h glycemia in the 140–199 mg/dL range.
In relation to the WC as a component of the MS, there 
are no specific cut-off points defined for the Brazilian 
Indian population. The option was to follow the more 
recent recommendations of the AHA/NHLBI [2], that 
men with WC ≥94  cm and women with WC ≥80  cm 
have higher risk to present cardiovascular diseases and 
diabetes mellitus. Also, these cut-off points are those 
more frequently adopted in recent publications.
Statistical analysis
Continuous data were expressed as proportions, means 
and standard deviations. Means were compared by the 
Student t test and the prevalence rates by the Chi square 
(χ2). Normality of distribution of the variables was tested 
using skewness/kurtosis test for normality (Kolmogo-
rov–Smirnov test) and all had approximately normal 
distribution. All analysis were performed using the soft-
ware statistical package for social sciences (SPSS) version 
17. The significance level was fixed at p < 0.05.
Results
A total of 932 individuals from both sexes (457 men, 475 
women) aged 20 years or more, were evaluated. Table 1 
presents means and standard deviations of age, clini-
cal, biochemical and anthropometric data, by gender of 
the study population. The mean age for the study popu-
lation was 42.7  ±  19.1  years, and was similar for both 
genders. The overall BMI mean was 30.3  ±  5.1, being 
slightly higher for women (30.8  ±  5.6 vs. 29.9  ±  4.6; 
p = 0.007). Women had mean values higher than men for 
basal and 2-h glycemia, HDL-cholesterol, WC and BMI. 
Systolic and diastolic blood pressure, weight and height 
were higher in men. There was no significant difference 
between genders in triglyceride levels.
Table  2 presents the distribution of the Xavante pop-
ulation, according to nutritional status, by gender and 
age-group. There was a high prevalence of weight excess, 
mainly in the age-groups of 20–39 and 40–59 years.
It was observed that 66.1 % (95 % CI 63.0–69.2) of the 
Xavante Indians presented MS, being 76.2  % (95  % CI 
72.4–80.0) in women and 55.6 % (95 % CI 51.0–60.2) in 
men, and the difference was significant (p < 0.001). The 
prevalence rates of MS were higher in women than in 
men, in all age-groups (Fig. 1).
Among women, 23.8 % presented less than three com-
ponents of the MS and all presented at least one of its 
components. Among men, the frequency of less than 
three components of the MS was 34.0 and 2.2  % (20 
individuals) did not have at least one of its component 
(Table 3).
Table 1 Mean and  standard deviation of  age, clinical, biochemical and  anthropometric data, by  gender in  the adult 
Xavante population from São Marcos and Sangradouro/Volta Grande Reservations, 2008–2012
* p < 0.01
Variables Mean ± SD p-value
Total
n = 932
Women
n = 475
Men
n = 457
Age (years) 42.7 ± 19.1 42.4 ± 19.3 43.1 ± 19.0 0.556
Basal glycemia (mg/dL) 152.5 ± 105.7 164.1 ± 113.8 140.6 ± 95.2 0.001*
2‑h glycemia (mg/dL) 148.7 ± 51.8 158.1 ± 49.0 140.1 ± 52.8 0.001*
HDL‑cholesterol (mg/dL) 38.9 ± 8.1 40.7 ± 8.2 37.1 ± 7.5 0.000*
Triglycerides (mg/dL) 199.0 ± 170.9 196.3 ± 179.4 201.8 ± 161.6 0.638
Systolic blood pressure (mm/Hg) 72.7 ± 10.8 71.5 ± 10.6 74.0 ± 10.9 0.000*
Diastolic blood pressure (mm/Hg) 122.3 ± 17.4 119.6 ± 18.5 125.0 ± 15.8 0.000*
Waist circumference (cm) 97.3 ± 10.9 98.6 ± 11.1 95.9 ± 10.4 0.000*
Weight (kg) 78.8 ± 15.3 74.0 ± 14.7 83.8 ± 14.2 0.000*
Height (m) 1.61 ± 0.08 1.55 ± 0.05 1.67 ± 0.05 0.000*
BMI (kg/m2) 30.3 ± 5.1 30.8 ± 5.6 29.9 ± 4.6 0.007*
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Elevated WC and lower levels of HDL-cholesterol were 
the most frequent components of the MS, and elevated 
blood pressure was the less frequent component (Table 4).
Among those with MS, the frequency of high blood 
pressure and elevated triglycerides were more frequent 
among men, whereas the other components were more 
frequent among women (Table 4).
Discussion
It was observed, in the last few decades, a process of 
approximation between the Xavante population and the 
urban communities of nearby cities of the Xavante Reser-
vations, which induced modifications in the relationship 
of the Indians with the land, work and their way of get-
ting foods.
Factors as territorial restrictions, exhaustion of natu-
ral resources, alterations in their pattern of settlement 
and loss of their nomadic life resulted in a more seden-
tary lifestyle of these Indians. They also incorporated sev-
eral foods from the Brazilian society and started to have 
industrialized foods, rich in sugar, fat and salt, and poor 
in proteins, fibers and several micronutrients [4, 7, 10, 16].
All these changes contributed to modify the epidemi-
ologic profile of these populations, with the increase in 
the prevalence of non-communicable diseases, as obesity, 
hypertension, type 2 diabetes and metabolic syndrome.
The results from the present study showed an elevated 
prevalence (66.1 %) of MS among the adult Xavante Indi-
ans, indicating a high risk for cardiovascular diseases and 
type 2 diabetes. This prevalence rate is higher than the 
most reported ones for Brazilians, either for indigenous 
populations [17–20] or non-indigenous [28].
Table 2 Distribution of  the adult Xavante population, 
from  the Indian Reservations of  São Marcos and  Sangra-
douro/Volta Grande, by gender, age-group and nutritional 
status, 2008–2012
Gender Nutritional status
Underweight Euthropic Weight excess Total
n (%) n (%) n (%) n (%)
Men
 20–39 years – 34 (12.9) 229 (87.1) 263 (57.5)
 40–59 years – 10 (9.1) 100 (90.9) 110 (24.1)
 ≥60 years 7 (8.3) 35 (41.7) 42 (50.0 84 (18.4)
 Sub‑total 7 (1.5) 79 (17.3) 371 (81.2) 457 (49.1)
Women
 20–39 years 1 (0.4) 24 (8.9) 245 (90.7) 270 (56.8)
 40–59 years – 7 (7.0) 93 (93.0) 100 (21.1)
 ≥60 years 13 (12.4) 41 (39.0) 51 (48.6) 105 (22.1)
 Sub‑total 14 (2.9) 72 (15.2) 389 (81.9) 475 (50.9)
General
 20–39 years 1 (0.2) 58 (10.9) 474 (88.9) 533 (57.2)
 40–59 years – 17 (8.1) 193 (91.9) 210 (22.5)
 ≥60 years 20 (10.6) 76 (40.2) 93 (49.2) 189 (20.3)
Total 21 (2.3) 151 (16.2) 760 (81.5) 932 (100.0)
Fig. 1 Prevalence of metabolic syndrome by gender and age‑group in the adult Xavante population of the São Marcos and Sangradouro/Volta 
Grande Reservations, 2008–2012
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A systematic review about the prevalence of MS in Bra-
zilian adults, selected ten studies, from which two were 
performed in indigenous populations, and the average 
prevalence was 29.6  % (14.9–65.3  %). The highest rate 
was observed among the Kaingang and Guarani (65.3 %), 
from the state of Rio Grande do Sul, being very similar to 
results from the present study [28].
Other studies with Indian populations found lower prev-
alence of MS, as 15.5 % in the Karib Indians from Upper 
Xingu [17], 21.9 % among the Indian Suya [9] and 27.8 % 
among the Khisêdjê [20], groups from the Xingu Indian 
Park, in the state of Mato Grosso; 23.3 % among the Kain-
gang Indians from the state of Rio Grande do Sul [18] and 
35.7 % among Indians from the village of Jaguapiru, in the 
municipality of Dourados, Mato Grosso do Sul [19].
Comparing the prevalence of MS from the present 
study with data published from other countries, it is pos-
sible to realize that the Xavante rate for MS is very supe-
rior than the reported rates for Portugal (27.6  %) [29], 
Spain (26.6  %) [30], France (25  % in men and 15.3  % in 
women) [31], Italy (28 % in men and 26 % in women) [32], 
United States of America (22.9 %) [33], Mexico (26.6 %) 
[34], Peru (18.1  %) [35], Chile (29.5  %) [36], North of 
Africa (30  %) [37], Colombia (34.8  %) [38], Venezuela 
(35.3  %) [39], China (33.9  %) [40] and Turkey (36.6  %) 
[41].
The same was observed when the rate from the Xavante 
population was compared with prevalence rates from 
indigenous populations from other countries, as 10 % in 
Siberia [42], 38  % in Argentina [43] and 46.9  % in Aus-
trália [44].
There are large differences in the prevalence of MS, 
according to the study population and the place of the 
study. Part of the differences are due to different diag-
nostic criteria to define the components of the MS, par-
ticularly the WC. The definition of the cut-off points for 
the WC, an important component to evaluate the central 
obesity, varies according the ethnicity, which limits this 
parameter in a multiethnic population.
The higher rates found among Xavante women are 
similar to the findings reported from other studies [9, 
17–20, 28]. These findings raises the hypothesis that 
other variables, not yet identified, may affect the associa-
tion between gender and presence of MS in the Indian 
population.
The Xavante Indians from the age-group 40–59  years 
were those with the higher rates of MS in relation to the 
younger and older age-groups. In a systematic review 
[28] about the prevalence of MS in Brazilian adults, it 
was described that the prevalence of MS increased with 
the age, being more elevated in individuals aged 50 years 
or more.
Table 3 Frequency of  the components of  metabolic 
syndrome, by  gender, in  the adult Xavante population 
from São Marcos and Sangradouro/Volta Grande Reserva-
tions, 2008–2012
Components of 
metabolic syndrome
Women
n (%)
Men
n (%)
Total
n (%)
None – (–) 20 (4.4) 20 (2.2)
1 24 (5.1) 77 (16.9) 101 (10.9)
2 88 (18.7) 105 (26.1) 193 (20.9)
3 143 (30.4) 139 (30.5) 282 (30.5)
4 151 (32.1) 88 (19.3) 239 (25.8)
5 64 (13.6) 26 (5.7) 90 (9.7)
Table 4 Frequency of  the components in  those with  metabolic syndrome, by  gender and  age-groups, in  the adult 
Xavante population from São Marcos and Sangradouro/Volta Grande Reservations, 2008–2012
Age-groups 
(years)
Components of metabolic syndrome (%)
Hypertension
n (%)
Low HDL- 
cholesterol 
n (%)
Elevated  
triglycerides 
n (%)
Hyper- 
glycemia
 n (%)
Elevated waist 
circumference 
n (%)
Women
 20–39 32 (18.2) 164 (93.2) 103 (58.5) 147 (83.5) 175 (99.4)
 40–59 40 (44.4) 85 (94.4) 68 (75.6) 84 (93.3) 90 (100.0)
 ≥60 49 (53.3) 79 (85.9) 67 (72.8) 82 (89.1) 88 (95.7)
 Sub‑total 121 (33.8) 328 (91.6) 238 (66.5) 313 (87.4) 353 (98.6)
Men
 20–39 56 (42.4) 110 (83.3) 108 (81.8) 73 (55.3) 113 (85.6)
 40–59 41 (52.6) 60 (76.9) 63 (80.8) 53 (67.9) 67 (85.9)
 ≥60 35 (81.4) 31 (72.1) 28 (65.1) 28 (65.1) 33 (76.7)
 Sub‑total 132 (52.5) 201 (79.4) 199 (78.7) 154 (60.9) 213 (84.2)
Total 253 (41.4) 529 (86.6) 437 (71.5) 467 (76.4) 566 (92.6)
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The fact that the Xavante Indians aged 60 years or more 
did not present the highest rates for MS can be explained 
by a less intense process of acculturation of the elderly, 
greater maintenance of their traditional habits and less 
contact with the Brazilian society due to language barri-
ers, resulting in lower changes in their life style, particu-
larly in the diet and physical activity.
Lower HDL-cholesterol levels were very frequent in 
other Brazilian studies with indigenous [17–20] and non-
indigenous [28] populations. In the Xavante population, 
besides their genetic background, could also contribute 
to the lower HDL-cholesterol levels, the reduction in 
their physical activities and a low consumption of nuts 
and monounsaturated fats.
The frequency of elevated WC was more frequent in 
the Xavante population than that reported in other Bra-
zilian Indian populations [17–20, 28]. Presently, there are 
no specific WC cut-off points proposed for the diagnosis 
of MS in the Indigenous population. Because of this lack 
of definition, several values are used. There is a need to 
define specific cut-off points for the WC for the Indian 
populations, that have differentiated structure and body 
composition.
Although relevant, high blood pressure was the less fre-
quent component of the MS in the Xavante. In a recent 
study [22], the age-adjusted prevalence of hypertension 
in this population was 17.5  %, which is below the aver-
age values reported for the general adult Brazilian pop-
ulation [45]. Results from the First National Health and 
Nutritional Survey in indigenous people [3] showed that 
13.1  % of the women aged 14–49  years presented high 
blood pressure. A systematic review about MS in the gen-
eral adult Brazilian population, showed that 52.5 % of the 
individuals had abnormal values for blood pressure [28].
Abnormalities in the glucose homeostasis are an 
important health problem among the Xavante popula-
tion. A recent survey [22] showed that the age-adjusted 
prevalence rates for diabetes and impaired glucose toler-
ance were 28.2 and 32.3 %, respectively.
The definition of a single cause or of multiple causes for 
the development of MS are still a challenge, but central 
obesity and insulin resistance have a key role in its Gene-
sis. With the hypertrophy of the adipose tissue, occurs an 
unbalance in the secretion of pro and anti-inflammatory 
adipokines, including the tumor necrosis factor alpha 
(TNF-α), the interleukin-6 (IL-6) and adiponectin, estab-
lishing a state of chronic inflammation of low intensity, 
that represents an important role in the development of 
obesity-related comorbidities. Concomitantly occurs an 
activation of pathways of inflammatory signals, as c-Jun 
N-terminal kinase (JNK) and transcription nuclear factor 
κB (NF-κB), that produces insulin resistance [46–49].
The high prevalence rate of MS in the Xavante Indians 
create a high risk for the development of cardiovascular 
diseases and type 2 diabetes. It is known that the pres-
ence of MS increases twofolds the risk for cardiovascular 
diseases and of fivefolds for type 2 diabetes [2, 50, 51].
In spite that these results are not representative of all 
Brazilian Indian populations, they are very important 
for the Xavante, since the size of our study sample cor-
responds to approximately 60 % of the adult population 
of the São Marcos and Sagradouro/Volta Grande reser-
vations. Our findings highlighted the importance of this 
health problem among the Xavante Indians and calls for 
the need for preventive measures towards risk factors for 
cardiovascular diseases.
Conclusions
The high prevalence of MS among the Xavante Indians, 
besides the genetic predisposition, is related to the high 
frequency of weight excess, due to changes in the pattern 
of food consumption and reduction in the frequency and 
intensity of physical activity. These results make an alert 
about the magnitude of this health problem, that will 
increase in a near future and resulting in a great impact 
in the quality of life of these Indians. There is an urgent 
need to have specific interventions towards prevention of 
risk factors for cardiovascular diseases.
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